Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

CompletedOBSERVATIONAL
Enrollment

208

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

October 25, 2023

Study Completion Date

October 25, 2023

Conditions
Plasma Cell Disorder
Interventions
DIAGNOSTIC_TEST

IUO Plasma Cell Disorders Panel

This Investigational Panel , comprised of 2 reagents , is intended for in vitro diagnostic use for qualitative flow-cytometric immunophenotyping of plasma cell populations. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having, plasma cell disorders.

Trial Locations (5)

37007

University of Salamanca, Salamanca

78229

Corepath Laboratories, San Antonio

Unknown

Champalimaud Foundation, Lisbon

Kantonsspital Aarau, Aarau

CB2 0QQ

Cambridge university hospital, Cambridge

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY